Cargando…

Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers, Volume II

Detalles Bibliográficos
Autores principales:	Lu, Qisi, Wang, Lihui, Zhang, Jian-ye, Yang, Dong-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036845/ https://www.ncbi.nlm.nih.gov/pubmed/36968996 http://dx.doi.org/10.3389/fonc.2023.1164399

Ejemplares similares

Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers
por: Wang, Lihui, et al.
Publicado: (2022)

Editorial: RNA modifications and epitranscriptomics, Volume II
por: Chen, Kunqi, et al.
Publicado: (2023)

Editorial: Molecular advances in diagnosis and treatment of CNS tumors, volume II
por: Chen, Clark, et al.
Publicado: (2023)

The Role of microRNA in Pathogenesis, Diagnosis, Different Variants, Treatment and Prognosis of Mycosis Fungoides
por: Wen, Pengfei, et al.
Publicado: (2021)

Editorial: Biomarkers in genitourinary cancers: Volume II
por: Yuasa, Takeshi
Publicado: (2022)

Editorial: COVID-19 and hematological malignancies: Volume II
por: Wilde, Lindsay, et al.
Publicado: (2022)

Editorial: Women in gastrointestinal cancers, volume II: 2022
por: Hamdy, Nadia M., et al.
Publicado: (2023)

Editorial: The application of artificial intelligence in diagnosis, treatment and prognosis in urologic oncology
por: Zhu, Xue-hua, et al.
Publicado: (2022)

Editorial: Hearing loss: from pathogenesis to treatment, volume II
por: Zou, Shengyu, et al.
Publicado: (2023)

Editorial: Women in head and neck cancer, volume II: 2022
por: Economopoulou, Panagiota, et al.
Publicado: (2023)

Editorial: Women in molecular and cellular oncology, volume II: 2022
por: Dhar, Shilpa S.
Publicado: (2023)

Editorial: Advances in the understanding of pathogenesis, diagnosis, and therapy of light chain amyloidosis
por: Bhutani, Divaya, et al.
Publicado: (2023)

Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2023)

Editorial: A Revised Approach to the Pathogenesis and Diagnosis of Myelodysplastic Syndromes With Therapeutic Implications
por: Aanei, Carmen Mariana, et al.
Publicado: (2018)

Editorial: Diagnosis, treatment and prognosis of viral hepatitis, volume II
por: Wu, Jian, et al.
Publicado: (2023)

Editorial: Prognostic research and precision oncology in upper tract urothelial carcinoma-volume II
por: Yang, Tsung-Mu, et al.
Publicado: (2023)

Editorial: Identification of therapeutic targets and novel biomarkers in prostate cancer volume II
por: Sharad, Shashwat, et al.
Publicado: (2023)

Editorial: Meningioma: From basic research to clinical translational study, volume II
por: Tang, Hailiang, et al.
Publicado: (2023)

Editorial: Immune-related adverse events for patients with lung cancer-volume II
por: Wang, Yusha, et al.
Publicado: (2023)

Editorial: Novel diagnostic and therapeutic strategies in the management of cerebral gliomas, Volume II
por: Bosio, Alberto, et al.
Publicado: (2023)

Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
por: Herling, Marco, et al.
Publicado: (2022)

Editorial: Diagnosis and treatment of bone metastases
por: Pu, Feifei, et al.
Publicado: (2023)

Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification
por: Yang, Qingfan, et al.
Publicado: (2022)

Editorial: Epigenetic Modifications in Mesothelioma
por: Cheng, Yuen Yee, et al.
Publicado: (2021)

Exosomes in Pathogenesis, Diagnosis, and Treatment of Hepatocellular Carcinoma
por: Li, Shuang, et al.
Publicado: (2022)

Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer, Volume II
por: Zhong, Weilong, et al.
Publicado: (2023)

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs, volume II
por: Yan, Miao, et al.
Publicado: (2023)

Editorial: Altered expression of proteins in cancer: function and potential therapeutic targets, volume II
por: Pessoa, João, et al.
Publicado: (2023)

Editorial: The mechanism of tumor evolution and microenvironmental changes of genitourinary oncology in clinical diagnosis and treatment
por: Lu, Jiahe, et al.
Publicado: (2023)

Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma
por: Yang, Kai-Bin, et al.
Publicado: (2021)

RNA Modifications and RNA Metabolism in Neurological Disease Pathogenesis
por: Chatterjee, Biswanath, et al.
Publicado: (2021)

Editorial: Diagnosis, prevention and treatment in diabetic nephropathy, volume II
por: Cecchini, Andrea Leonardo, et al.
Publicado: (2023)

Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)

Editorial: The Role of lncRNA in Cancer Metabolism
por: Huang, Guo-Liang, et al.
Publicado: (2021)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

Editorial: The Role of Epigenetic Modifications in Cancer Progression
por: Fujimura, Atsushi, et al.
Publicado: (2021)

Editorial: Plant cell wall in pathogenesis, parasitism and symbiosis, Volume II
por: Vicré, Maïté, et al.
Publicado: (2023)

Editorial: Machine learning-based methods for RNA data analysis—Volume II
por: Peng, Lihong, et al.
Publicado: (2022)

Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II
por: Gill, Harinder, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_990pkr8ofcu28mrkqsmetuhn1v